Genetic deletion of αSMA in mouse models enhances the progression of pancreatic ductal adenocarcinoma (PDAC) as evidenced by a lower survival rate in αSMA-depleted mice (Ozdemir et al., 2014). Here, ACTA1 is linked to pancreatic ductal adenocarcinoma.